Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAPBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FXR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NXF2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OTUD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LGALS9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOV10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H2BD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1QL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHMP4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFI30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CASP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HARBI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMB8-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTPAL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLCAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060835 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on